Up to now, more than 150 companies and institutions in China have been engaged in genetic sequencing related business, and competition has become increasingly hot. The industry pointed out that the current highly sought-after precision medical treatment is a bit overheated, and because of the lack of core intellectual property technology products, the current cost of genetic testing is too high; with the development of precision medicine, the pathology department has also developed new problems: unprecedented lack of people. Recently, the Shanghai Economic and Information Commission issued the "Notice on the Implementation of the 2017 Special Report on the Development of Shanghai Informatization Development (Big Data Development) Project". Gene sequencing, precision medicine , and big data disease prevention can be subsidized by Shanghai 5 million. For major projects approved by the municipal government, the support ratio and amount may not be limited by the above support standards. Previously, for genetic testing and precision medicine, the state has introduced a series of encouraging support policies. With this background and future demand growth, capital has also begun to be popular. Xue Yuansheng, a senior consultant at Jun Medical Research Center, said that from 2005 to 2013, China's gene sequencing industry has won 20 investment and financing projects, 2014 to 2016. In March of the year, the number of industry investment and financing surged to 28. However, in Xue Yuansheng's view, as of now, more than 150 companies and institutions in China have engaged in gene sequencing-related businesses, and competition has become increasingly hot. At the same time, Professor Shao Jianyong, director of the Department of Molecular Diagnostics at the Cancer Hospital of Sun Yat-Sen University, who has been engaged in genetic testing at the first line, also pointed out to reporters that the current highly regarded precision medical treatment is a bit overheated, and because of the lack of core intellectual property technology products, At present, the cost of genetic testing is too high; the chairman of the Pathology Branch of the Chinese Medical Association and Professor Bu Hong of West China Hospital of Sichuan University pointed out that with the development of precision medicine, the pathology department also has new problems: unprecedented lack of people. Antitumor And Chemotherapy Antiemetic Antitumor And Chemotherapy Antiemetic,Tropisetron Hydrochloride Tablets,Tablets Of Tropisetron Hydrochloride,Tablets For Antitumor And Antiemetic Shandong Qidu Pharmaceutical Co., Ltd. , https://www.qdyypharma.com